No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CWEN Clearway Energy-C
- 24.370
- +0.260+1.08%
Close Jul 3 13:00 ET
- 24.530
- +0.160+0.66%
Post 16:26 ET
2.85BMarket Cap37.49P/E (TTM)
24.810High24.180Low732.94KVolume24.290Open24.110Pre Close17.86MTurnover0.63%Turnover Ratio36.37P/E (Static)117.07MShares28.71052wk High1.39P/B2.83BFloat Cap17.70152wk Low1.57Dividend TTM116.32MShs Float37.444Historical High6.45%Div YieldTTM2.61%Amplitude9.302Historical Low24.367Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Clearway Energy to Acquire Luna Valley Solar and Daggett Solar Power
Clearway Energy (CWEN), through its subsidiary LV-Daggett Parent Holdco, has entered into a membership interest purchase agreement to acquire limited liability interests in Luna Valley Solar I and Da
Express News | NYSE Order Imbalance 55795.0 Shares on Buy Side
UBS Raises Clearway Energy's Price Target to $33 From $32, Maintains Buy Rating
Clearway Energy (CWEN.A) has an average rating of Buy and price targets ranging from $25 to $34, according to analysts polled by Capital IQ.
Clearway Energy Is Maintained at Outperform by Evercore ISI Group
Clearway Energy Is Maintained at Outperform by Evercore ISI Group
Express News | Evercore ISI Group Maintains Outperform on Clearway Energy, Raises Price Target to $30
Clearway Energy Is Maintained at Buy by Roth MKM
Clearway Energy Is Maintained at Buy by Roth MKM
Comments
$Clearway Energy-C(CWEN.US$
Solid!![]()
- Quarterly dividend declared up 1.7%, $0.4102 per share.
- Target annual dividend per share growth in the upper range of 5% - 8% through 2026
Solid!
- Quarterly dividend declared up 1.7%, $0.4102 per share.
- Target annual dividend per share growth in the upper range of 5% - 8% through 2026
The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
alphaedgeinvest...
$Clearway Energy-C(CWEN.US$
alphaedgeinvest...
$Clearway Energy-C(CWEN.US$
1
The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
alphaedgeinvest...
$Clearway Energy-C(CWEN.US$
alphaedgeinvest...
$Clearway Energy-C(CWEN.US$
1
Gapping up
In reaction to earnings/guidance:
• $Coty Inc(COTY.US$ +3.9%, $General Mills(GIS.US$+2.6%
Other news:
• $Clene(CLNN.US$ +5.3% (announces presentation of updated survival results from the Phase 2 RESCUE-ALS trial open-label extension)
• $Clearway Energy-C(CWEN.US$ +2.5% (Provides operational update on El Segundo Energy Center)
• $Apartment Income(AIRC.US$ +2.4% (provides operating update)
• $Alpine Immune(ALPN.US$ +2.3% (...
In reaction to earnings/guidance:
• $Coty Inc(COTY.US$ +3.9%, $General Mills(GIS.US$+2.6%
Other news:
• $Clene(CLNN.US$ +5.3% (announces presentation of updated survival results from the Phase 2 RESCUE-ALS trial open-label extension)
• $Clearway Energy-C(CWEN.US$ +2.5% (Provides operational update on El Segundo Energy Center)
• $Apartment Income(AIRC.US$ +2.4% (provides operating update)
• $Alpine Immune(ALPN.US$ +2.3% (...
9
1
for your Forsite and more 
Gainers:
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
18
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
